These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
208 related items for PubMed ID: 22261010
21. Midnight salivary cortisol for the initial diagnosis of Cushing's syndrome of various causes. Yaneva M, Mosnier-Pudar H, Dugué MA, Grabar S, Fulla Y, Bertagna X. J Clin Endocrinol Metab; 2004 Jul; 89(7):3345-51. PubMed ID: 15240613 [Abstract] [Full Text] [Related]
22. Screening for subclinical Cushing's syndrome in type 2 diabetes mellitus: low false-positive rates with nocturnal salivary cortisol. Gagliardi L, Chapman IM, O'Loughlin P, Torpy DJ. Horm Metab Res; 2010 Apr; 42(4):280-4. PubMed ID: 20119887 [Abstract] [Full Text] [Related]
23. Advantage of salivary cortisol measurements in the diagnosis of glucocorticoid related disorders. Restituto P, Galofré JC, Gil MJ, Mugueta C, Santos S, Monreal JI, Varo N. Clin Biochem; 2008 Jun; 41(9):688-92. PubMed ID: 18280810 [Abstract] [Full Text] [Related]
24. A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome. Castro M, Elias LL, Elias PC, Moreira AC. Clin Endocrinol (Oxf); 2003 Dec; 59(6):800-5. PubMed ID: 14974925 [Abstract] [Full Text] [Related]
25. New diagnostic criteria of adrenal subclinical Cushing's syndrome: opinion from the Japan Endocrine Society. Yanase T, Oki Y, Katabami T, Otsuki M, Kageyama K, Tanaka T, Kawate H, Tanabe M, Doi M, Akehi Y, Ichijo T. Endocr J; 2018 Apr 26; 65(4):383-393. PubMed ID: 29576599 [Abstract] [Full Text] [Related]
26. In the overnight dexamethasone suppression test, 1.0 mg loading is superior to 0.5 mg loading for diagnosing subclinical adrenal Cushing's syndrome based on plasma dexamethasone levels determined using liquid chromatography-tandem mass spectrometry. Sasaki Y, Katabami T, Asai S, Fukuda H, Tanaka Y. Endocr J; 2017 Sep 30; 64(9):833-842. PubMed ID: 28637948 [Abstract] [Full Text] [Related]
30. [How to screen for pheochromocytoma, primary aldosteronism and Cushing's syndrome]. Meyer P. Rev Med Suisse; 2009 Jan 07; 5(185):15-8. PubMed ID: 19216319 [Abstract] [Full Text] [Related]
31. Which type 2 diabetes mellitus patients should be screened for subclinical Cushing's syndrome? Cansu GB, Atılgan S, Balcı MK, Sarı R, Özdem S, Altunbaş HA. Hormones (Athens); 2017 Jan 07; 16(1):22-32. PubMed ID: 28500825 [Abstract] [Full Text] [Related]
33. Late-night salivary cortisol measurement in the diagnosis of Cushing's syndrome. Carroll T, Raff H, Findling JW. Nat Clin Pract Endocrinol Metab; 2008 Jun 07; 4(6):344-50. PubMed ID: 18446140 [Abstract] [Full Text] [Related]
34. Reproducibility of nighttime salivary cortisol and its use in the diagnosis of hypercortisolism compared with urinary free cortisol and overnight dexamethasone suppression test. Viardot A, Huber P, Puder JJ, Zulewski H, Keller U, Müller B. J Clin Endocrinol Metab; 2005 Oct 07; 90(10):5730-6. PubMed ID: 16014408 [Abstract] [Full Text] [Related]